Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 14;196(3):548–558. doi: 10.1111/bjh.17877

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Fig 1 — Anti‐SARS‐CoV‐2 S titres in lymphoid malignancy (LM) patients and healthy subjects. Comparison between LM patients and age‐ and sex‐matched healthy controls (A). Anti‐SARS‐CoV‐2 levels in LM patients seronegative at baseline according to: treatment status (B), treatment with anti‐CD20 plus chemotherapy or other therapies (C), absolute lymphocyte count (ALC) at the moment of the first dose (D), IgM (E), IgG (F), and IgA (G) levels at the moment of the first dose and according to other treatments (H).